These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22677319)

  • 1. Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.
    Sams AG; Larsen K; Mikkelsen GK; Hentzer M; Christoffersen CT; Jensen KG; Frederiksen K; Bang-Andersen B
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5134-40. PubMed ID: 22677319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors.
    Butini S; Campiani G; Franceschini S; Trotta F; Kumar V; Guarino E; Borrelli G; Fiorini I; Novellino E; Fattorusso C; Persico M; Orteca N; Sandager-Nielsen K; Jacobsen TA; Madsen K; Scheel-Kruger J; Gemma S
    J Med Chem; 2010 Jun; 53(12):4803-7. PubMed ID: 20481570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.
    Chen Y; Wang S; Xu X; Liu X; Yu M; Zhao S; Liu S; Qiu Y; Zhang T; Liu BF; Zhang G
    J Med Chem; 2013 Jun; 56(11):4671-90. PubMed ID: 23675993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.
    Yan Y; Zhou P; Rotella DP; Feenstra R; Kruse CG; Reinders JH; van der Neut M; Lai M; Zhang J; Kowal DM; Carrick T; Marquis KL; Pausch MH; Robichaud AJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2983-6. PubMed ID: 20347298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M; Lim HD; Herenbrink CK; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2015 Feb; 58(3):1550-5. PubMed ID: 25590655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potential antipsychotic agents possessing pro-cognitive properties.
    Lameh J; McFarland K; Ohlsson J; Ek F; Piu F; Burstein ES; Tabatabaei A; Olsson R; Bradley SR; Bonhaus DW
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):313-23. PubMed ID: 22083558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Aminoindanes as novel motif with potential atypical antipsychotic properties.
    Graham JM; Coughenour LL; Barr BM; Rock DL; Nikam SS
    Bioorg Med Chem Lett; 2008 Jan; 18(2):489-93. PubMed ID: 18160289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    Bucki A; Marcinkowska M; Śniecikowska J; Zagórska A; Jamrozik M; Pawłowski M; Głuch-Lutwin M; Siwek A; Jakubczyk M; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M
    Eur J Med Chem; 2020 Apr; 191():112149. PubMed ID: 32105980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.
    Cid JM; Tresadern G; Vega JA; de Lucas AI; Matesanz E; Iturrino L; Linares ML; Garcia A; Andrés JI; Macdonald GJ; Oehlrich D; Lavreysen H; Megens A; Ahnaou A; Drinkenburg W; Mackie C; Pype S; Gallacher D; Trabanco AA
    J Med Chem; 2012 Oct; 55(20):8770-89. PubMed ID: 23072213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M(1) and M(4) muscarinic acetylcholine receptors agonists.
    Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4644-7. PubMed ID: 23816371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
    Zajdel P; Marciniec K; Maślankiewicz A; Grychowska K; Satała G; Duszyńska B; Lenda T; Siwek A; Nowak G; Partyka A; Wróbel D; Jastrzębska-Więsek M; Bojarski AJ; Wesołowska A; Pawłowski M
    Eur J Med Chem; 2013 Feb; 60():42-50. PubMed ID: 23279866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics.
    Favor DA; Powers JJ; White AD; Fitzgerald LW; Groppi V; Serpa KA
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5666-9. PubMed ID: 20801650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
    Huang L; Gao L; Zhang X; Yin L; Hu J; Song T; Chen Y
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127506. PubMed ID: 32828898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening.
    Lowe J; Drozda S; Qian W; Peakman MC; Liu J; Gibbs J; Harms J; Schmidt C; Fisher K; Strick C; Schmidt A; Vanase M; Lebel L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1675-8. PubMed ID: 17257843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
    Shultz MD; Cao X; Chen CH; Cho YS; Davis NR; Eckman J; Fan J; Fekete A; Firestone B; Flynn J; Green J; Growney JD; Holmqvist M; Hsu M; Jansson D; Jiang L; Kwon P; Liu G; Lombardo F; Lu Q; Majumdar D; Meta C; Perez L; Pu M; Ramsey T; Remiszewski S; Skolnik S; Traebert M; Urban L; Uttamsingh V; Wang P; Whitebread S; Whitehead L; Yan-Neale Y; Yao YM; Zhou L; Atadja P
    J Med Chem; 2011 Jul; 54(13):4752-72. PubMed ID: 21650221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands.
    Furlotti G; Alisi MA; Apicella C; Capezzone de Joannon A; Cazzolla N; Costi R; Cuzzucoli Crucitti G; Garrone B; Iacovo A; Magarò G; Mangano G; Miele G; Ombrato R; Pescatori L; Polenzani L; Rosi F; Vitiello M; Di Santo R
    J Med Chem; 2012 Nov; 55(22):9446-66. PubMed ID: 23043420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.
    Heinrich JN; Butera JA; Carrick T; Kramer A; Kowal D; Lock T; Marquis KL; Pausch MH; Popiolek M; Sun SC; Tseng E; Uveges AJ; Mayer SC
    Eur J Pharmacol; 2009 Mar; 605(1-3):53-6. PubMed ID: 19168056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.